Medication Training Via Ignite Based on Roy Model in Heart Failure: Medication Adherence and Symp… (NCT07538596) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Medication Training Via Ignite Based on Roy Model in Heart Failure: Medication Adherence and Symptom Management
Turkey (Türkiye)70 participantsStarted 2026-04-15
Plain-language summary
The goal of this clinical trial is to learn if a structured medication training program can help people with heart failure better manage their condition. The program is based on the Roy Adaptation Model and is designed to support how people adjust to their illness.
The main questions it aims to answer are:
Does the training program improve heart failure symptoms? Does the training program help participants take their medications as prescribed?
Researchers will compare a training program group to a control group receiving standard care to see if the program is effective.
Participants will:
Be randomly assigned to either a training program group or a control group Receive the training program through WhatsApp after hospital discharge or receive standard discharge education Be followed for 12 weeks Complete questionnaires at the start of the study, at 4 weeks, and at 12 weeks
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Must be 18 years of age or older.
* Individuals who are willing to participate in the study
* No communication problems
* Having been diagnosed with KY for at least 6 months
* Having the ability to read, write and speak Turkish .
* Mildly reduced ejection fraction (left ventricular EF 41-49%)
* Individuals with WhatsApp application
* Individuals who can use a smartphone
Exclusion Criteria:
* Not being willing to participate in the study don't be under the age of 18
* Lack of ability to read, write and speak Turkish
* Low ejection fraction (left ventricle EF. 40%)
* Preserved ejection fraction (left ventricular EF.50%)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.